Renal news roundup from AKF

Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, has been found to improve hemoglobin levels in patients with type 2 diabetes and chronic kidney disease (CKD), ...

Maze Therapeutics has secured $115 million in a Series D funding round led by Frazier Life Sciences and Deep Track Capital, with participation from Janus Hender...

A study in BMC Pulmonary Medicine suggested that angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may lower the risk of ventilator-ass...

A study from the Icahn School of Medicine at Mount Sinai highlights the severe impact of acute kidney injury in COVID-19 patients, showing a high mortality rate...

In a study focusing on the effects of aspirin in patients with CKD, researchers found that aspirin did not reduce the incidence of nonfatal atherosclerotic card...

Veterans receiving as-needed blood pressure medication during hospitalization have a 23% higher risk of AKI and are 1.5 times more likely to experience rapid bl...

Continuous and portable dialysis has been a long-sought goal for treating patients living with kidney disease, as traditional dialysis sessions can last up to f...

Sherri Somerville donated one of her kidneys to her husband, Calvin, after discovering she was a match against the odds. Sherri, who was already registered as a...

GLP-1 receptor agonists (RAs) may decrease the progression of kidney disease in patients with lupus nephritis, according to studies presented at the American Co...